Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations.
about
Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developmentsPrevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.New developments in the pathology of malignant lymphoma: a review of the literature published from October 2009 to January 2010EBV-positive diffuse large B-cell lymphoma of the elderlyThe 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applicationsEBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management.Gene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathwaysA microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderly.Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab eraEBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment.Diffuse large B-cell lymphoma in human T-lymphotropic virus type 1 carriers.Epstein-Barr Virus-Positive Diffuse Large B cell Lymphoma in the Experience of a Tertiary Medical Center in Poland.Epstein-barr virus infection in an elderly nonimmunocompromised adult successfully treated with rituximab.Clinicopathologic characterization of diffuse-large-B-cell lymphoma with an associated serum monoclonal IgM component.A Literature Revision in Primary Cutaneous B-cell LymphomaEpstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far.Strong cross-talk between angiogenesis and EBV: do we need different treatment approaches in lymphoma cases with EBV and/or high angiogenic capacity.Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies.Epstein-Barr virus-associated diffuse large B-cell lymphoma: diagnosis, difficulties and therapeutic options.EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management.Patients with activated B-cell like diffuse large B-cell lymphoma in high and low infectious disease areas have different inflammatory gene signatures.Cytotoxic response against Epstein Barr virus coexists with diffuse large B-cell lymphoma tolerogenic microenvironment: clinical features and survival impact.Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma.Computed tomography findings in Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) of the elderly: comparison with EBV-negative DLBCL.Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells.Age and cellular composition influence overall survival in a collective of non-immunocompromised patients with EBV-positive diffuse large B-cell lymphoma from a German lymphoma center.Intrafollicular Epstein-Barr virus-positive large B cell lymphoma. A variant of "germinotropic" lymphoproliferative disorder.Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphoma.In Europe expression of EBNA2 is associated with poor survival in EBV-positive diffuse large B-cell lymphoma of the elderly.Hydrocephalus as the sole presentation of primary diffuse large B-cell lymphoma of the brain: Report of a case and review of literature.[Cutaneous lymphomas: new entities and rare variants].Epstein-Barr virus-negative diffuse large B-cell lymphoma hosts intra- and peritumoral B-cells with activated Epstein-Barr virus.Clinical characteristics and treatment outcome in a Taiwanese population of patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.Detection of the Epstein-Barr virus in blood and bone marrow mononuclear cells of patients with aggressive B-cell non-Hodgkin's lymphoma is not associated with prognosis.Integrated copy number and gene expression profiling analysis of Epstein-Barr virus-positive diffuse large B-cell lymphoma.CD30 expression in de novo diffuse large B-cell lymphoma: a population-based study from British Columbia.Epstein-Barr virus-positive diffuse large B-cell lymphoma association is not only restricted to elderly patients.EBV-positive MTX-diffuse large B cell lymphoma in a rheumatoid arthritis patient.Primary central nervous system Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a clinicopathologic study of five cases.
P2860
Q26775442-4D659E5D-CB0F-4DB5-93B9-3B5612094008Q33583294-8C173700-805B-486A-AFF5-E9A0D4CB9F8BQ33906881-639EC625-A92F-4B4B-99D8-846F8C5A821FQ34343242-1F5B1981-C397-4617-9E47-C28D47F2FF6EQ35029409-E9F426E7-F6AC-412F-B51F-A947F39DA2E2Q35040644-A3F194C9-942E-4CC5-B659-18666D1DF36CQ35051575-30892848-AFC8-451F-95DE-6F692A0A7F89Q35067988-A82C3C95-D7ED-439C-BBF6-F436C35221A0Q35713686-D8EFA866-9B73-4A0F-8F21-12F7DD40C59DQ35953524-5443C9C3-FE87-4C07-A7F8-2076B595A8D9Q36422084-1141F6FD-A16E-437E-ABA1-864757FBFF35Q36723872-89509CAC-C97D-4824-9ED2-E8ECE8004BF7Q37602937-F96848F4-2DED-410D-B37C-3701F63991F4Q37685724-FC99338D-59EF-4F77-951E-BBEACCA7F273Q37717714-70F894C7-7863-41E0-A29C-D65786D11504Q37826599-C0DF6BF8-CCE4-4989-8644-1F48E67E89BCQ37938966-E98A6130-04EF-4011-BEAC-9D3A6F15CAB2Q38188591-44D3CC65-4DD6-4A2E-B716-C4B0DE4DDBA8Q38720593-4145E78C-D5BA-4B9C-AC25-5D24E3A35629Q38812004-EB79EE9A-19C2-44F4-AB75-8370E96E3B2FQ39090962-435ED3A0-F272-4FEA-991B-F251E7FA5D50Q40052180-103DDF89-EBEB-4485-B04A-BDF481B331B4Q40150053-269A9F14-B7C8-4C35-B374-2B5D83F49D51Q40309812-311DA350-86E2-4E3D-A79C-69D6BCEEBD4FQ40321829-A6DFFDBD-59C2-4F1B-9838-64D6989F0DC0Q40696036-1316AF21-0E81-4862-8772-B43BC235114AQ40834878-D993A6CF-845E-4926-A881-471599BEF4BAQ40956947-35EE88E2-6D4A-42B1-8BB3-DC9AEC00F88EQ41000926-C85F6986-B6EA-47AE-8FC8-6F9372551C2CQ41300276-26C458E0-26E3-4C1F-80EA-C4066E3254B9Q41339462-30A3F3FD-274E-4ABF-B9FF-16F47CC7E858Q41544587-B4270444-E92F-4DCD-9A88-43E31DACC797Q41691346-63D16DF2-C8D2-4634-B3E2-F57C11A7BD1AQ41699036-BF4C1A4F-F80C-4323-A1E1-168BDEDAC207Q41862441-014CF314-DAB2-4EA9-B0CD-BD9BDA89C814Q42151219-3C061272-CAB4-418B-A500-EAFB502F5025Q42199195-C401E136-B8F4-41E3-ADB3-D3B614D9C0FCQ42220952-7E7C74D8-F023-4C58-99C7-092EACDEA2DAQ42244137-6B587F11-D42B-4479-91FB-1FF9D7AFA292Q42244659-41CC7141-2E4B-4921-A3B6-31C333B39367
P2860
Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Epstein-Barr virus-positive di ...... s rare in Western populations.
@en
Epstein-Barr virus-positive di ...... s rare in Western populations.
@nl
type
label
Epstein-Barr virus-positive di ...... s rare in Western populations.
@en
Epstein-Barr virus-positive di ...... s rare in Western populations.
@nl
prefLabel
Epstein-Barr virus-positive di ...... s rare in Western populations.
@en
Epstein-Barr virus-positive di ...... s rare in Western populations.
@nl
P2093
P1433
P1476
Epstein-Barr virus-positive di ...... s rare in Western populations.
@en
P2093
Philip Went
Stefano A Pileri
Stephan Dirnhofer
Sylvia Hoeller
P304
P356
10.1016/J.HUMPATH.2009.07.024
P407
P577
2009-11-13T00:00:00Z